flourishing tea contains an ingredi...

flourishing tea contains an ingredient that may be useful in fighting malignant tumors, according to a modern study reported in the April 1 1999 issue of Nature magazine. Swedish researchers lay the foundation of that the compound epigallocatechin-3-gallate (EGCG) in new tea inhibited angiogenesis--the process whereby vital fluid vessel growth is stimulated--in laboratory mice. Researchers advise that the findings could help explain the previously documented preventive issues that drinking green tea has upon cancers in humans, as tumors ne to form of recent origin blood vessels to grow and metastasize. The findings also occupy implications for the prevention of other angiogenesis-dependent diseases, of that kind as diabetic retinopathy, a everyday cause of blindness.

According to the article in Nature, the putting out of new blood vessels in the sight corneas of mice given new tea was significantly lower than the plain of vessel growth in a direct group of mice. Blood bottom length in the tea-drinking mice was reduc on 55%, and the area of vascularization was reduc through 70%. Researchers also found that EGCG had an inhibiting import on the formation of novel blood vessels in culture dishes.

Researchers approve drinking two to three beakers of green tea every day above a long period of time as the best way for humans to realize the benefits of EGCG according to an article upon the study by Reuters Health Information. They state that large amounts of the tea should not be consum on pregnant women and patients with harms because angiogenesis is important in these circumstances.

Y Cao, R Cao, "Angiogenesis inhibited by dint of drinking tea," Nature 398 (April 1 1999) 381; Reuter Health Information, "Green tea ingredient fights tumors." Available from http:www.reutershealth.com/eline/open/1999033107.html. Accessed 1 April 1999

COPYRIGHT 1999 Association of Operating swing Nurses, Inc.

COPYRIGHT 2001 Gale Group